BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170503
DTEND;VALUE=DATE:20170604
DTSTAMP:20260729T155000
CREATED:20170502T185227Z
LAST-MODIFIED:20170505T115812Z
UID:17780-1493769600-1496534399@ces.b2sg.org
SUMMARY:Postdoctoral Positions - Gene Regulation\, Epigenetics and/or Cancer Biology
DESCRIPTION:Postdoctoral associate positions available for highly motivated candidates with a fresh PHD training in molecular & cell biology\, cancer biology and/or biochemistry to join the Lineberger Comprehensive Cancer Center\, the Department of Biochemistry & Biophysics\, University of North Carolina at Chapel Hill (UNC) School of Medicine\, USA. Those with a strong publication track record are also potentially eligible for a two-year postdoctoral fellowship program available from UNC Cancer Center Postdoc Trainee programs (eligibility: 1\, within less than 1-2 years since completion of PHD training; 2\, US citizen or permanent resident). \nOur laboratory emphasizes on mechanistic understandings of gene regulation\, chromatin biology\, stem cells\, and human disease\, notably cancer (see our recent publications at Molecular Cell 2013\, Blood 2015\, Cell Reports 2015; Cancer Cell 2016). Multiple on-going projects include (1) biochemical characterization of novel factors/complexes that recognize the novel chromatin modifications; (2) CRISPR/dCas9-based editing of epigenomic modifications for understanding the epigenetic pathways in gene expression; (3) knockout and knock-in mouse models with deficiency in histone methylation regulation in context of development and tumorigenesis\, with a special focus on hematopoietic cancer and disease; (4) epigenomic and transcriptome analyses (ChIP-Seq and RNA-Seq) of normal versus cancer cells to delineate pathways essential for tumor growth. \nThe salary of postdoc positions meets new federal Fair Labor Standards Act (FLSA) with a minimum salary of $47\,476 annually. Applicants should be self-motivated with a track record of publication in the above area\, have laboratory and analytical skills\, and be a critical thinker. Application shall include CV\, a cover letter (with summary of research experiences and future interests\, and expected availability date) reprints of publications\, and contact information of three references. The application materials should be sent to gregwang.unc@gmail.com. \nThe University of North Carolina at Chapel Hill is an equal opportunity and affirmative action employer.
URL:https://ces.b2sg.org/event/postdoc-epigenetics-cancer-bio/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
END:VCALENDAR